These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 35276734)
1. COVID-19 in cancer patients. Seneviratne SL; Wijerathne W; Yasawardene P; Somawardana B Trans R Soc Trop Med Hyg; 2022 Sep; 116(9):767-797. PubMed ID: 35276734 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry. Borno HT; Kim MO; Hong JC; Yousefi S; Lin A; Tolstykh I; Zhang S; McKay RR; Harismendy O; Cinar P; Rugo H; Koshkin VS; Rabow M; Wang C; Bailey A; Small EJ Oncologist; 2022 May; 27(5):398-406. PubMed ID: 35348771 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccination in cancer patients: a narrative review. Seneviratne SL; Yasawardene P; Wijerathne W; Somawardana B J Int Med Res; 2022 Mar; 50(3):3000605221086155. PubMed ID: 35313761 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 in pediatric cancer: a systematic review. Schlage S; Lehrnbecher T; Berner R; Simon A; Toepfner N Eur J Pediatr; 2022 Apr; 181(4):1413-1427. PubMed ID: 35006377 [TBL] [Abstract][Full Text] [Related]
5. Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana. Lunski MJ; Burton J; Tawagi K; Maslov D; Simenson V; Barr D; Yuan H; Johnson D; Matrana M; Cole J; Larned Z; Moore B Cancer; 2021 Jan; 127(2):266-274. PubMed ID: 33112411 [TBL] [Abstract][Full Text] [Related]
6. Comorbidities of COVID-19 Patients. Silaghi-Dumitrescu R; Patrascu I; Lehene M; Bercea I Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629683 [TBL] [Abstract][Full Text] [Related]
8. Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity Lau MC; Yi Y; Goh D; Cheung CCL; Tan B; Lim JCT; Joseph CR; Wee F; Lee JN; Lim X; Lim CJ; Leow WQ; Lee JY; Ng CCY; Bashiri H; Cheow PC; Chan CY; Koh YX; Tan TT; Kalimuddin S; Tai WMD; Ng JL; Low JG; Lim TKH; Liu J; Yeong JPS Front Immunol; 2022; 13():978760. PubMed ID: 36172383 [TBL] [Abstract][Full Text] [Related]
9. An Overview on COVID-19 and its Effect on Cardiovascular Diseases. Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840 [TBL] [Abstract][Full Text] [Related]
10. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions. Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry. Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K; Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569 [TBL] [Abstract][Full Text] [Related]
12. COVID-19: a conundrum to decipher. Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923 [TBL] [Abstract][Full Text] [Related]
13. The intersection of COVID-19 and cancer: signaling pathways and treatment implications. Zong Z; Wei Y; Ren J; Zhang L; Zhou F Mol Cancer; 2021 May; 20(1):76. PubMed ID: 34001144 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Comorbidities in Survivors and Non-Survivors of Severe COVID-19 at a Dedicated COVID Care Centre. Siddiqi Z; Fatima J; Bhatt D; Shukla V; Malik M; Ashfaq A; Masakputra V; Barbhuyan A J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062800 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 immunization in people with cancer-Is it safe and efficient? What do we know? Lazăr DE; Munteanu A Tumori; 2022 Oct; 108(5):420-430. PubMed ID: 35426773 [TBL] [Abstract][Full Text] [Related]
16. Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic wave. Fong D; Mair MJ; Lanthaler F; Alber M; Mitterer M Int J Cancer; 2022 Feb; 150(3):431-439. PubMed ID: 34610144 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
18. Thyroid cancer in the Era of COVID-19. Smulever A; Abelleira E; Bueno F; Pitoia F Endocrine; 2020 Oct; 70(1):1-5. PubMed ID: 32754886 [TBL] [Abstract][Full Text] [Related]
19. Preexisting comorbidities shape the immune response associated with severe COVID-19. Kreutmair S; Kauffmann M; Unger S; Ingelfinger F; Núñez NG; Alberti C; De Feo D; Krishnarajah S; Friebel E; Ulutekin C; Babaei S; Gaborit B; Lutz M; Jurado NP; Malek NP; Göpel S; Rosenberger P; Häberle HA; Ayoub I; Al-Hajj S; Claassen M; Liblau R; Martin-Blondel G; Bitzer M; Roquilly A; Becher B J Allergy Clin Immunol; 2022 Aug; 150(2):312-324. PubMed ID: 35716951 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database. Dong X; Zhou Y; Shu XO; Bernstam EV; Stern R; Aronoff DM; Xu H; Lipworth L Microbiol Spectr; 2021 Sep; 9(1):e0032721. PubMed ID: 34406805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]